<<
>>

Литература

  Aas IH (1995). Incentives and financing methods. Health Policy, 34(3):205—220.

Albreht T et al. (2002). Health care systems in transition: Slovenia. Health Systems in Transition, 4(3):1—89.

Allin S, Davaki K, Mossialos E (2006). Paying for ‘free’ health care: the conundrum of informal payments in post-communist Europe. Global corruption report 2006. Berlin, Transparency International.

Arsenopoulou I et al. (2009). Greece: health system review. Health Systems in Transition (готовится к печати).

Bach P (2008). Cost sharing for health care — whose skin? Which game? New England Journal of Medicine (24 January), 358:411—413.

Balabanova D, McKee M (2002). Understanding informal payments for health care: the example of Bulgaria. Health Policy, 62:243—273.

Barnum H, Kutzin J, Saxenian H (1995). Incentives and provider payment methods. International Journal of Health Planning amp; Management, 10(1):23—45.

Barr N (2004). The economics of the welfare state (4th edition). Oxford, Oxford University Press.

Barrientos A, Lloyd-Sherlock P (2000). Reforming health insurance in Argentina and Chile. Health Policy Plan, 15(4):417-423.

Barros P, de Almeida Simoes J (2007). Portugal: health system review. Health Systems in Transition, 9(5):1—140.

Bartholomee Y, Maarse H (2006). Health insurance reform in the Netherlands. EuroHe- alth, 12(2):7—9.

BBC (2006) [интернет-сайт]. New clampdown on carousel fraud. London, British Broadcasting Corporation (http://news.bbc.co.uk/1/hi/business/5204422.stm, accessed 23 November 2007).

Berki SE (1986). A look at catastrophic medical expenses and the poor. Health Affairs, 5:139—145.

Bibbee A, Padrinin F (2006). Balancing health care quality and cost-containment: the case of Norway. Paris, Organisation for Economic Co-operation and Development (OECD Economics Department Working Papers No.

481).

Bitran R et al. (2000). Equity in the financing of social security for health in Chile. Health Policy, 50(3):171—196.

Boccuti C, Moon M (2003). Comparing Medicare and private insurers: growth rates in spending over three decades. Health Affairs, 22(2):230—237.

Boyle S (2008). The UK health system. New York, Commonwealth Fund (http://www.commonwealthfund.org/usr_doc/UK_Country_Profile_2008.pdf?section= 4061, accessed 29 November 2008).

Braithwaite R, RosenAB (2007). Linking cost sharing to value: an unrivaled yet unrealized public health opportunity. Annals of Internal Medicine, 146(8):602—605.

Bramley-Harker E et al. (2006). Mind the gap: sustaining improvements in the NHS beyond 2008. London, NERA Economic Consulting, Frontier Economics and BUPA. Breuil-Genier P (2000). Generaliste puis specialiste: un parcours peu frequent. INSEE Premiere, 709, April.

Buchner F, Wasem J (2003). Needs for further improvement: risk adjustment in the German health insurance system. Health Policy, 65(1):21—35.

Bundesministerium fur Gesundheit (2007). Welcome to solidarity!Information on the 2007 health reform. Bonn, Bundesministerium fur Gesundheit.

Busse R (2001). Risk structure compensation in Germany’s statutory health insurance. European Journal of Public Health, 11(2):174—177.

Busse R (2008). The health system in Germany. New York, The Commonwealth Fund (http://www.commonwealthfund.org/usr_doc/Germany_Country_Profile_2008_2.pdf? section= 4061, accessed 29 November 2008).

Busse R, Riesberg A (2004). Health care systems in transition: Germany. Health Systems in Transition, 6(9):1—234.

Busse R, Schlette S (eds) (2007). Health policy developments 7/8. Gutersloh, Bertelsmann Stiftung.

Busse R, Schreyogg J, Smith PC (2006). Editorial: hospital case payment systems in Europe. Health Care Management Science, 9:211—213.

Busse R, Worz M (2004). The ambiguous experience with privatization in German health care.

In Maarse H. Privatization in European health care: a comparative analysis in eight countries. Maarssen, Elsevier Gezondheidszorg: 79—95.

Cerniauskas G, Murauskiene L, Tragakes E (2000). Health care systems in transition: Lithuania. Copenhagen, WHO Regional Office for Europe.

Chaix-Couturier C et al. (2000). Effects of financial incentives on medical practice: results from a systematic review of the literature and methodological issues. International Journal for Quality in Health Care, 12(2):133—142.

Charpentier C, Samuelson L (1999). Effekter av en Sjukvardsreform: en analys av Stockholmsmodellen [Effect of health care reform: an analysis of the Stockholm model]. Sollentuna, Nerenius and Santerus Forlag.

Commission on Macroeconomics and Health (2001). Macroeconomics and health: investing in health for economic development. Geneva, Commission on Macroeconomics and Health.

CorensD(2007). Belgium: health system review. Health Systems in Transition, 9(2):1—172. Couffinhal A, Habicht T (2005). Health system financing in Estonia. Copenhagen, WHO Regional Office for Europe.

Council of the European Union (2006). Council conclusions on common values and principles in EU health systems. Brussels, Council of the European Union (http://eur-lex.europa. eu/LexUriServ/site/en/oj/2006/c_146/c_14620060622en00010003. pdf, accessed 10 November 2007).

Cutler D (2004). Your money or your life. Oxford, Oxford University Press.

Cutler D, McClellan M (2001). Is technological change in medicine worth it? Health Affairs (Millwood), 20(5):11—29.

den Exter A, Hermans HE, Dosljak M (2004). Health care systems in transition: the Netherlands. Health Systems in Transition, 6(6):1—151.

Department of Health (2005). Resource allocation weighted capitation formula, fifth edition. London, Department of Health.

Deppe HU, Oreskovic S (1996). Back to Europe: back to Bismarck? InternationalJournal of Health Services, 26(4):777—802.

Diderichsen F, Varde E, Whitehead M (1997). Resource allocation to health authorities: the quest for an equitable formula in Britain and Sweden. British Medical Journal, 315:875-878.

Dismuke CE, Sena V (1999). Has DRG payment influenced the technical efficiency and productivity of diagnostic technologies in Portuguese public hospitals? An empirical analysis using parametric and non-parametric methods. Health Care Management Science, 2(2):107—116.

Docteur E, Oxley H (2003). Health care systems: lessons from the reform experience. Paris, Organisation for Economic Co-operation and Development (OECD Health Working Papers 9). Donatini A et al. (2009). Italy: health system review. Health Systems in Transition (готовится к печати).

Dourgnon P (2005). Choice in the French health care system. Euro Observer, 6(4):9—11. Duran A, Lara JL, van Waveren M (2006). Spain: health system review. Health Systems in Transition, 8(4):1—208.

Durand-Zaleski I (2008). The French health care system. New York, The Commonwealth Fund (http://www.commonwealthfund.org/usr_doc/France_Country_Profile_2008.pdf? section= 4061, accessed 29 November 2008).

Economic Policy Committee (2001). Budgetary challenges posed by ageing populations: the impact of public spending on pensions, health and long-term carefor the elderly and possible indicators of the long-term sustainability of public finances. Brussels, Council of the European Union (EPC/ ECFIN/655/01-EN final).

Economic Policy Committee and European Commission (2006). The impact of ageing on public expenditure: projections for the EU25 Member States on pensions, health care, long-term care, education and unemployment transfers. Brussels, European Commission. Ensor T (2004). Informal payments for health care in transition economies. Social Science amp; Medicine, 58(2):237—246.

Ensor T, Duran-Moreno A (2002). Corruption as a challenge to effective regulation in the health sector. In: Saltman R, Busse R, Mossialos E. Regulating entrepreneurial behaviour in European health care systems. Buckingham, Open University Press:106—124.

Ensor T, Tompson R (1998). Health insurance as a catalyst for change in former communist countries? Health Policy, 43:203—218.

Esposito D (2002). You get what you co-pay for: The influence of patient co-payments on the demandfor drugs within a therapeutic class: The case of the statins. Santa Barbara, UC Santa Barbara.

Ettelt S etal. (2006). Reimbursing highly specialized hospital services: the experience of activity-based funding in eight countries. A report commissioned by the Department of Health and prepared by the London School of Hygiene and Tropical Medicine. London, London School of Hygiene and Tropical Medicine.

Ettelt S et al. (2007). The systematic use of cost—effectiveness criteria to inform reviews of publicly funded benefits packages. A report commissioned by the Department of Health and prepared by the London School of Hygiene and Tropical Medicine. London, London School of Hygiene and Tropical Medicine.

European Commission (2005). Working together, working better: a newframeworkfor the open coordination of social protection and inclusion policies in the European Union. Communication from the Commission to the Council, the European Parliament, the European Economic and Social Committee and the Committee of the Regions. Brussels, European Commission. European Commission (2007a). Directive on services in the internal market. Brussels, European Commission (http://ec.europa.eu/internal_market/services/services-dir/index_en. htm, accessed 10 November 2007).

European Commission (2007b). Insurance: Commission scrutinises exemption of Irish voluntary health insurance board from EU rules. Brussels, European Commission (IP/07/87, 24 January 2007).

European Commission (2007c). Eurostat statistical data. Brussels, European Commission. European Communities (1992). Council Directive 92/49/EEC of 18 June 1992 on the coordination of laws, regulations and administrative provisions relating to direct insurance other than life assurance and amending Directives 73/239/EEC and 88/357/EEC (Third non-life insurance directive). Official Journal of the European Community, L 228(11 August):1—23.

ECJ (2006). Case T-84/06, Pending Case, Azivo Algemeen Ziekenfonds De Volharding v Commission. Luxembourg, European Court of Justice.

Evans RG (1984). Strained mercy: the economics of Canadian health care. Toronto, Butterworths.

Evans RG, Barer ML (1995). User fees for health care: why a bad idea keeps coming back (or, what’s health got to do with it?). Canadian Journal on Aging, 14(2):360—390.

Fattore G, Torbica A (2006). Inpatient reimbursement system in Italy: How do tariffs relate to costs? Health Care Management Science, 9:251—258.

Figueras J, Robinson R, Jakubowski E (2005). Purchasing to improve health systems performance: drawing the lessons. In: Figueras J, Robinson R, Jakubowski E. Purchasing to improve health systems performance. Buckingham, Open University Press:44—80.

Fisher ES etal. (2003a). The implications of regional variations in Medicare spending. Part 1: The content, quality, and accessibility of care. Annals of Internal Medicine, 138(4):273— 287.

Fisher ES et al. (2003b). The implications of regional variations in Medicare spending. Part 2: Health outcomes and satisfaction with care. Annals of Internal Medicine, 138(4):288— 298.

Forgione DA et al. (2004). The impact of DRG-based systems on quality of health care in OECD countries. Journal of Health Care Finance, 31(1):41—54.

FoubisterT, Thomson S, Mossialos E (2004). Health care financing in ten central and eastern European countries. Неопубликованные данные.

Foubister T et al. (2006). Private medical insurance in the United Kingdom. Copenhagen, WHO Regional Office for Europe.

Fuchs V (2004). More variation in use of care, more flat-of-the-curve medicine. Health Affairs (7 October):104—105.

Gaal P, Riesberg A (2004). Health care systems in transition: Hungary. Health Systems in Transition, 6(2):1—152.

Gemmill M, Thomson S, Mossialos E (2007). What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries. International Journal of Equity in Health, 7(12):1—22.

Georgieva L et al. (2007). Bulgaria: Health system review. Health Systems in Transition, 9(1):1—156.

GlenngardAHetal. (2005). Health systems in transition: Sweden. Health Systems in Transition, 7(4):1—128.

Golna C et al. (2004). Health care systems in transition: Cyprus. Health Systems in Transition, 6(5):1—117.

Grabowski HG, Vernon JM (1992). Brand loyalty, entry and price competition in pharmaceuticals after the 1984 drug act. Journal of Law and Economics, 35(2):331—350.

Gresz S et al. (2002). Free choice of sickness fund in regulated competition: evidence from Germany and the Netherlands. Health Policy, 60(3):235—254.

Habicht J et al. (2006). Detecting changes in financial protection: creating evidence for policy in Estonia. Health Policy and Planning, 21(6):421 —431.

Health Insurance Institute of Slovenia (2006) [интернет-сайт]. Ljubljana, Health Insurance Institute of Slovenia (www.zzzs.si, accessed 16 November 2007).

Heffler S et al. (2004). Health spending projections through 2013. Health Affairs (11 February): W4—79.

Henshall C et al. (1997). Priority setting for health technology assessment: theoretical considerations and practical approaches. International Journal of Technology Assessment in Health Care, 13:144-185.

Hervey T (2007). EU law and national health policies: problem or opportunity? Health Economics, Policy and Law, 2(1):1—6.

Hlavacka S, Wagner R, RiesbergA(2004). Health care systems in transition: Slovakia. Health Systems in Transition, 6(10):1—118.

Hofmarcher M, Rack H (2006). Austria: health system review. Health Systems in Transition, 8(3):1—247.

Hong SH, Shepherd MD (1996). Outpatient prescription drug use by children enrolled in five drug benefit plans. Clinical T erapeutics, 18(3):528—545.

Jarvelin J (2002). Health care systems in transition: Finland. Health Systems in Transition, 4(1):1—92.

Jesse M et al. (2004). Health care systems in transition: Estonia. Health Systems in Transition, 6(11):1—142.

Jonsson B (1996). Cost sharing for pharmaceuticals — the Swedish reimbursement system. Pharmacoeconomics, 10(Suppl. 2):68—74.

JostTS (2000). Private or public approaches to insuring the uninsured: lessons from international experience with private insurance. New York University Law Review, 76(2):419— 492.

Karaskevica J, Tragakes E (2001). Health care systems in transition: Latvia. Copenhagen, WHO Regional Office for Europe.

Keen M, Kim K, Varsano R (2006). The “flat tax(es)”: Principles and evidence. Washington, DC, International Monetary Fund (IMF Working Paper WP/06/218).

Kerr E (1999). Health care systems in transition: Luxembourg. Health Systems in Transiti- on:1—68.

Kjerstad E (2003). Prospective funding of general hospitals in Norway — incentives for higher production? International Journal of Health Care Finance and Economics, 3(4):231 — 251.

Klazinga N (2008). The health system in the Netherlands. New York, The Commonwealth Fund (http://www.commonwealthfund.org/usr_doc/Netherlands_Country_Profile_ 2008.pdf?section=4061, accessed 29 November 2008).

Kuszewski K, Gericke C (2005). Health systems in transition: Poland. Health Systems in Transition, 7(6):1—106.

Kutzin J (2001). A descriptive framework for country-level analysis of health care financing arrangements. Health Policy, 56(3):171—203.

Lewis M (2002a). Informal health payments in central and eastern Europe and the former Soviet Union: issues, trends and policy implications. In: Mossialos E et al. Fundinghealth care: options for Europe. Buckingham, Open University Press:184—205.

Lewis M (2002b). Who is paying for health care in eastern Europe and central Asia? Washington, DC, World Bank.

Lewis R, Curry N, Dixon M (2007). Practice-based commissioning: from good idea to effective practice. London, The King’s Fund.

Lexchin J, Grootendorst P (2004). Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence. International Journal of Health Services, 34(1):101—122.

Lisac M (2006). Health care reform in Germany: not the big bang. Health Policy Monitor, November 2006 (http://www.hpm.org/survey/de/b8/2j accessed 10 November 2007). Louis DZ et al. (1999). Impact of a DRG-based hospital financing system on quality and outcomes of care in Italy. Health Services Research, 34(1):405—415.

Maarse H, Bartholomee Y (2006). Apublic—private analysis of the new Dutch health insurance system. European Journal of Health Economics, 8(1):77—82.

Manning WG et al. (1987). Health insurance and the demand for medical care: evidence from a randomized experiment. American Economic Review, 77(3):251 —277.

Marchildon G (2005). Health systems in transition: Canada. Health Systems in Transition, 7(3):1—156.

Maynard A, Street A (2006). Health service reform. Seven years of feast, seven years of famine: boom to bust in the NHS? British Medical Journal, 332:906—908.

McDaid D, Wiley MM (2009). Ireland: health system review. Health Systems in Transition (готовится к печати).

McKee M, Mossialos E, Baeten R (eds) (2002). The impact of EU law on health care systems. Brussels, P.I.E.-Peter Lang.

MGEN (2006). Missions of economic general interest carried out by mutual societies in Europe, between economic activity and social services. Brussels, Mutuelle Generale de l’Education Nationale.

Mielck A, Helmert U (2006). Vergleich zwischen GKV- und PKV-Versicherten: Unterschiede bei Morbiditat und gesundheitlicher Versorgung. In: Bocken Jet al. (eds). Gesundheitsmonitor. Gutersloh, Bertelsmann Stiftung:32—52.

Mikkola H, Keskimaki I, Hakkinen U (2001). DRG-related prices applied in a public health care system — can Finland learn from Norway and Sweden? Health Policy, 59(1):37—51.

Milenkovic Kramer A (2006). Is voluntary health insurance in Slovenia really a success story? Unpublished dissertation prepared at the London School of Economics and Political Science.

Ministry of Health of the Government of the Republic of Slovenia (2007) [интернет-сайт]. Ljubljana, Ministry of Health of the Government of the Republic of Slovenia (www.mz.gov.si, accessed 16 November 2007).

Ministry of Health, Welfare and Sport (2007) [интернет-сайт]. Health insurance system. The Hague, Netherlands Ministry of Health, Welfare and Sport (http://www.minvws.nl/ en/themes/health-insurance-system/default.asp, accessed 23 November 2007).

MISSOC (2007). Social protection in the Member States of the European Union, of the European Economic Area and in Switzerland: situation on 1 January 2007. Brussels, European Commission (http://ec.europa.eu/employment_social/spsi/missoc_tables_en.htm#table2007, accessed 18 December 2007).

Mortimer R (1997). Demandfor prescription drugs: The effects of managed care pharmacy benefits. Berkeley, University of California Berkeley Economics Department.

Mossialos E, Dixon A (2002). Funding health care in Europe: an introduction. In: Mossialos E et al. Funding health care: options for Europe. Buckingham, Open University Press:1—30.

Mossialos E, Le Grand J (1999). Cost-containmentintheEU: an overview. In: Mossialos E, Le Grand J. Health care and cost-containment in the European Union. Aldershot, Ashga- te:1—154.

Mossialos E, McKee M (2002). Health care and the European Union. British Medical Journal, 324(7344):991—992.

Mossialos E, Thomson S (2002). Voluntary health insurance in the European Union: a critical assessment. International Journal of Health Services, 32(1):19—88.

Mossialos E et al. (2002a). EU law and the social character of health care. Brussels, P.I.E.-Peter Lang.

Mossialos E et al. (2002b). Funding health care: options for Europe. Buckingham, Open University Press.

Mossialos E, Thomson S (2004). Voluntary health insurance in the European Union. Copenhagen, WHO Regional Office for Europe.

MurthyA, Mossialos E (2003). Informal payments in EU accession countries. Euro Observer, 5(2):1—3.

Muscat N (1999). Health care systems in transition: Malta. Copenhagen, WHO Regional Office for Europe.

National Institute for Strategic Health Research (2007). Hungarian health system scan, June 2007. Budapest, National Institute for Strategic Health Research (ESKI).

Newey C et al. (2004). Avoidable mortality in the enlarged European Union. Paris, Institut des Sciences de la Sante.

Newhouse J P and The Insurance Experiment Group (1993). Free for all? Lessons from the RAND health insurance experiment. Cambridge and London, Harvard University Press. Nolte E, McKee M (2003). Measuring the health of nations: analysis of mortality amenable to health care. British Medical Journal, 327(7424):1129—1133.

Nolte E, McKee M (2004). Does health care save lives?Avoidable mortality revisited. London, The Nuffield Trust.

Nolte E, McKee M (2008). Measuring the health of nations: updating an earlier analysis. Health Affairs, 27(1):58—71.

OECD (2006). Health data 2006. Paris, Organisation for Economic Co-operation and Development (http://www.oecd.org/, accessed 29 November 2008).

OECD (1992). The reform of health care: a comparative analysis of seven OECD countries. Paris, Organisation for Economic Co-operation and Development.

OECD (2004). Private health insurance in OECD countries. Paris, Organisation for Economic Co-operation and Development.

OECD (2007). Revenue statistics 1965—2006. Paris, Organisation for Economic Co-operation and Development.

Offer A (2003). Why has the public sector grown so large in market societies? The political economy of prudence in the UKc.1879—2000. Oxford, Oxford University Press.

Office of Fair Trading (1996). Health insurance: a report by the Offi ce of Fair Trading. London, Office of Fair Trading.

Office of Fair Trading (1998). Health insurance: a second report by the Office of Fair Trading. London, Office of Fair Trading.

Olivarius N F, Jensen FI, Pedersen PA (1990). Epidemiologic study of persons having group 2 insurance in Denmark. 1. Historical development, social and demographic differences between health insurance groups 1 and 2. UgeskrLaeger 152(20): 1443—1446.

Olivarius NF et al. (1994). Self-referral and self-payment in Danish primary care. Health Policy, 28(1):15—22.

Oliver AJ, Mossialos E (2005). European health system reforms: looking backward to see forward? Journal of Health Politics, Policy and Law, 30(1—2):7—28.

Pauly MV (1969). A measure of the welfare cost of health insurance. Health Services Research, 4(4):281 —292.

Pierson P (1998). Irresistible forces, immovable objects: post-industrial welfare states confront permanent austerity. Journal of European Public Policy, 5(4):539—560.

Polikowski M, Santos-Eggimann B (2002). How comprehensive are the basic packages of health services? An international comparison of six health insurance systems. Journal of Health Services Research amp; Policy, 7(3):133—142.

Preker AS, Jakab M, Schneider M (2002). Health financing reforms in central and eastern Europe and the former Soviet Union. In Mossialos E et al. Funding health care: options for Europe. Buckingham, Open University Press:80—108.

Puig-JunoyJ (1999). Managing risk selection incentives in health sector reforms. International Journal of Health Planning and Management, 14:287—311.

Reinhardt UE, Hussey PS, Anderson GF (2004). US health care spending in an international context. Health Affairs, 23(3):10—25.

Rice N, Smith PC (2002). Strategic resource allocation and funding decisions. In: Mossialos E et al. Funding health care: options for Europe. Buckingham, Open University Press:250—271.

Rice T, Morrison KR (1994). Patient cost sharing for medical services: a review of the literature and implications for health care reform. Medical Care Research amp; Review, 51(3):235—287.

Riesberg A (2005). Choice in the German health care system. Euro Observer, 6(4):6—9. Robinson R (1999). Health care systems in transition: United Kingdom. Health Systems in Transition, 1—117.

Rogers R et al. (2005). HRG drift and payment by results. British Medical Journal, 330:563-564.

Rokosova M et al. (2005). Health care systems in transition: Czech Republic. Health Systems in Transition, 7(1):1—100.

Saltman RB, Figueras J (1998). Analysing the evidence on European health care reforms. Health Affairs (Millwood), 17(2):85-108.

Sandier S et al. (2004). Health care systems in transition: France. Health Systems in Transition, 6(2):1—145.

Sapelli C (2004). Risk segmentation and equity in the Chilean mandatory health insurance system. Social Science amp; Medicine, 58(2):259—265.

Schneider F (2002). The size and development of the shadow economies of the 22 transition and 21 OECD countries. Bonn, Institute for the Study of Labour (Discussion Paper No 514).

Schneider M (2003). Structure and experience of German opt-out system of statutory health insurance (GKV). Washington, DC, World Bank.

Schneider P (2007). Provider payment reforms: lessons from Europe and America for south eastern Europe. Washington, DC, World Bank.

Schoen C et al. (2005). Insured but not protected: how many adults are underinsured? Health Affairs, 14 June:289—302.

Schreyogg J et al. (2005). Defining the “health benefit basket” in nine European countries: evidence from the European Union Health BASKET Project. European Journal of Health Economics, 6(Supplement 1):2—10.

Schut F, Gresz S, Wasem J (2003). Consumer price sensitivity and social health insurer choice in Germany and the Netherlands. International Journal of Health Care Finance and Economics, 3(2):117—139.

Schwartz F, Busse R (1996). Fixed budgets in the ambulatory care sector: the German experience. In: Schwartz F, Glennerster H, Saltman R. Fixing health budgets: experience from Europe and North America. London, Wiley:239.

Securite Sociale (2008) [интернет-сайт]. Contrat responsable. Paris, Securite Sociale de la France (http://www.securite-sociale.fr/comprendre/reformes/reformeassmal/decrets/ maitrise/20050930.htm, accessed 23 January 2008).

Seshamani M, Gray A (2004). Age, proximity to death andfuture demands on the NHS. London, Office of Health Economics

Smith PC, YorkN (2004). Quality incentives: thecase of UK general practitioners. Health Affairs 23(3):112—118.

Sorenson C, Kanavos P, Drummond M (2007). Report 3: Ensuring value for money in health care: the role of HTA in the European Union. In: CoxPetal. The Cox report on financing sustainable healthcare in Europe (http://www.sustainhealthcare.org/cox.php, accessed 23 November 2007):139-162.

Suhrcke M et al. (2005). The contribution of health to the economy in the European Union. Brussels, European Commission.

Suhrcke M et al. (2006). Investment in health could be good for Europe’s economies. British Medical Journal, 333(11 November):1017—1019.

Tamblyn R et al. (2001). Adverse effects associated with prescription drug cost-sharing among poor and elderly persons. Journal of the American Medical Association, 285(4):421—429.

The Healthcare Commission (2005). The Healthcare Commission’s review of NHSfoundati- on trusts. London, The Healthcare Commission.

Thomson S, Balabanova D, PolettiT (2009). What role for voluntary health insurance? In: Kutzin J, Busse R, Schreyogg J. Implementing health financing reforms: lessons from andfor countries in transition. Maidenhead, Open University Press (готовится к печати). Thomson S, Busse R, Mossialos E (2002). Low demand for substitutive voluntary health insurance in Germany. Croatian Medical Journal, 43(4):425—432.

Thomson S, Mossialos E (2004). Funding health care from private sources: what are the implications for equity, efficiency, cost-containment and choice in western European health systems? Copenhagen, WHO Regional Office for Europe. />Thomson S, Mossialos E (2006). Choice of public or private health insurance: learning from the experience of Germany and the Netherlands. Journal of European Social Policy, 16(4): 315-327.

Thomson S, Mossialos E (2007a). EU law and regulation of private health insurance. Health Economics, Policy and Law, 2(2):117—124.

Thomson S, Mossialos E (2007b). Regulating private health insurance in the European Union: the implications of single market legislation and competition policy. Journal of European Integration, 29(1):89—107.

Thomson S, Mossialos E, Jemiai N (2003). Cost sharing for health services in the European Union. Report prepared for the European Commission Directorate General for Employment and Social Affairs. London, London School of Economics and Political Science. Vallgarda S, Krasnik A, Vrangb?k K (2001). Health care systems in transition: Denmark. Health Systems in Transition, 3(7):1 —92.

van de Ven WPMM, Ellis RP (1999). Risk adjustment in competitive health plan markets. In: NewhouseJP, CulyerAJ. Handbook of health economics. Amsterdam, Elsevier:755—645. van de Ven WPMM et al. (2003). Risk adjustment and risk selection on the sickness fund insurance market in five European countries. Health Policy, 65(1):75—98. van de Ven WPMM et al. (2007). Risk adjustment and risk selection in Europe: six years later. Health Policy, 83(2—3):162—179.

van Doorslaer E, Koolman X, Puffer F (2002). Equity in the use of physician visits in OECD countries: has equal treatment for equal need been achieved? In: OECD. Measuring up: improving health systems performance in OECD countries. Paris, Organisation for Economic Co-operation and Development :225—248.

van Doorslaer E, Masseria C, Koolman X (for the OECD Health Equity Research Group) (2006). Inequalities in access to medical care by income in developed countries. Canadian Medical Association Journal, 174(2):177—183.

Van Hulle K (2007). European integration and healthcare systems. Presentation given at the 2nd INAMI Symposium, Brussels, 28 September 2007.

Velasco-Garrido M, Busse R (2005). Health technology assessment: an introduction to objectives, role of evidence and structure in Europe. Copenhagen, WHO Regional Office for Europe.

Verhoeven M, Gunnarsson V, Lugaresi S (2007). The health sector in the Slovak Republic: efficiency and reform. Washington, DC, International Monetary Fund (IMF Working Paper WP/07/226).

Vladescu C, Scintee S, Olsavsky V (2008). Romania: health system review. Health Systems in Transition, 10(3):1—181.

Vladescu C et al. (2000). Health care systems in transition: Romania. Copenhagen, WHO Regional Office for Europe.

VrangbakK(2009). The health system in Denmark. New York, The Commonwealth Fund (готовится к печати).

Vuorenkoski L (2008). Finland: health system review. Health Systems in Transition, 10(4):1—170.

Wagstaff A et al. (1992). Equity in the finance ofhealth care: some international comparisons. Journal of Health Economics, 11(4):361—387.

Wagstaff A et al. (1999). Equity in the finance ofhealth care: some further international comparisons. Journal of Health Economics, 18(3):263—290.

White C (2006). GP contract settlement under threat. British Medical Journal, 332(7532):10.

WHO (2000). The world health report 2000: health systems — improving performance. Geneva, World Health Organization.

WHO (2007a). The new Dutch health insurance scheme: challenges and opportunities for better performance in health financing. Geneva, World Health Organization (Health System Financing Discussion Paper, No 3).

WHO (2007b). World health statistics 2007. Geneva, World Health Organization.

WHO Regional Office for Europe (2006). Approaching health financing policy in the WHO European region. Paper prepared for the WHO Regional Committee for Europe, fifty-sixth session, Copenhagen, 11—14 September 2006. Copenhagen, WHO Regional Office for Europe.

Wyszewianski L (1986). Financially catastrophic and high-cost cases: definitions, distinctions, and their implication for policy formulation. Inquiry, 23:382—394.

Xu K et al. (2003). Household catastrophic health expenditure: a multicountry analysis. The Lancet, 362(12 July):111-117.

Yates J (1995). Private eye, heart and hip. Edinburgh, Churchill Livingstone.

Zentner A, Velasco-Garrido M, Busse R (2005). Methods for the comparative evaluation of pharmaceuticals. GMS Health Technology Assessment, 1(9) (http://www.egms.de/en/jo- urnals/hta/2005-1/hta000009.shtml, accessed 29 November 2008).

Zok K (1999). Anforderungen an die Gesetzliche Krankenversicherung: Einschatzungen und Erwartungen aus Sicht der Versicherten. Bonn, Wissenschaftliches Institut der AOK.

Zweifel P, Felder S, Meiers M (1999). Ageing of population and health care expenditure: a red herring? Health Economics, 8(6):485—496.

Zweifel P, Felder S, Werblow A (2004). Population ageing and health care expenditure: new evidence on the “red herring”. The Geneva Papers on Risk and Insurance Theory, 29:652-666.

<< | >>
Источник: Thomson S., Foubister T., Mossialos E. Финансирование здравоохранения в Европейском союзе. 2010

Еще по теме Литература:

  1. Рекомендуемые источники и литература
  2. Литература 1.
  3. II. Литература 47.
  4. ЛОМОНОСОВ В ИСТОРИИ РУССКОЙ ЛИТЕРАТУРЫ И РУССКОГО ЯЗЫКА1
  5. Литература
  6. 5. ВАВИЛОНСКАЯ ЛИТЕРАТУРА 41
  7. Вавилонсая литература.
  8. § 1. Язык философии и язык литературы: entrelacements
  9. § 2. Литература как письмо - «странный институт»
  10. Литература
  11. ЛИТЕРАТУР А
  12. СЕРБСКАЯ, ХОРВАТСКАЯ И СЛОВЕНСКАЯ ЛИТЕРАТУРА
  13. ЧЕШСКАЯ И СЛОВАЦКАЯ ЛИТЕРАТУРА
  14. ЛИТЕРАТУРА ИРАНА
  15. 3.2.1. ИЗУЧЕНИЕ ПРОИЗВЕДЕНИЙ РУССКОЙ ЛИТЕРАТУРЫ НА ЭТНОКУЛЬТУРНОЙ ОСНОВЕ В НАЦИОНАЛЬНОЙ ШКОЛЕ